Literature DB >> 7979506

Biosynthetic human growth hormone treatment in the UK: an audit of current practice. Kabi Pharmacia International Growth Study.

D A Price1, D I Johnston, P R Betts, J M Buckler, M D Donaldson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7979506      PMCID： PMC1029987          DOI： 10.1136/adc.71.3.266

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  11 in total

1.  The Kabi Pharmacia International Growth Study: aetiology classification list with comments.

Authors:  M B Ranke
Journal:  Acta Paediatr Scand Suppl       Date:  1991

2.  Growth hormone secretion enhanced by androgens.

Authors:  L G Martin; J W Clark; T B Connor
Journal:  J Clin Endocrinol Metab       Date:  1968-03       Impact factor: 5.958

3.  Leukaemia in patients treated with growth hormone.

Authors: 
Journal:  Lancet       Date:  1988-05-21       Impact factor: 79.321

4.  Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.

Authors:  M B Ranke; O Guilbaud; A Lindberg; T Cole
Journal:  Acta Paediatr Suppl       Date:  1993-09

5.  A prospective, randomized study of testosterone treatment of constitutional delay of growth and development in male adolescents.

Authors:  R G Rosenfeld; G B Northcraft; R L Hintz
Journal:  Pediatrics       Date:  1982-06       Impact factor: 7.124

6.  Investigation of suspected growth hormone deficiency. On behalf of the Health Services Human Growth Hormone Committee.

Authors:  R D Milner; E C Burns
Journal:  Arch Dis Child       Date:  1982-12       Impact factor: 3.791

7.  The possible influence of puberty on the release of growth hormone in three males with apparent isolated growth hormone deficiency.

Authors:  R Penny; R M Blizzard
Journal:  J Clin Endocrinol Metab       Date:  1972-01       Impact factor: 5.958

8.  Experience with human growth hormone in Great Britain: the report of the MRC Working Party.

Authors:  R D Milner; T Russell-Fraser; C G Brook; P M Cotes; J W Farquhar; J M Parkin; M A Preece; G J Snodgrass; A S Mason; J M Tanner; F P Vince
Journal:  Clin Endocrinol (Oxf)       Date:  1979-07       Impact factor: 3.478

9.  Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.

Authors:  C R Buchanan; M A Preece; R D Milner
Journal:  BMJ       Date:  1991-04-06

10.  Oxandrolone in low dose for constitutional delay of growth and puberty in boys.

Authors:  R Stanhope; C G Brook
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791
View more
  3 in total

Review 1.  A rational approach to short stature: focus on use and abuse of growth hormone.

Authors:  J Krishna
Journal:  Indian J Pediatr       Date:  1997 Mar-Apr       Impact factor: 1.967

2.  Response to growth hormone therapy in Indian patients.

Authors:  M K Garg; R Pakhetra; M K Dutta; A Gundgurthi
Journal:  Indian J Pediatr       Date:  2010-06-08       Impact factor: 1.967

3.  Uk audit of childhood growth hormone prescription, 1998.

Authors:  J Hilken
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.